This is a routine tax-withholding sale tied to vesting, no bearish signal. Monitor for any unplanned open-market sales by Oyler in coming weeks; the 06/08 sale of 4,940 ADSs was larger but still modest relative to his position. No immediate trading action warranted.
ONC drugs
ONC drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 12 $264.48entry
- T+1 · 5mo ago +1.41%α −0.36% · $268.20
- T+5 · 5mo ago +2.14%α +1.47% · $270.15
- T+20 · 4mo ago +12.94%α +11.16% · $298.70
- T+60 · 2mo ago +32.89%α +29.63% · $351.48
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director John Oyler filed a Form 144 notice of intent to sell 1,949 ADSs (~$501K) of BeOne Medicines Ltd. (ONC), with proceeds going to cover tax withholding on restricted stock vesting. The sale is a routine tax-motivated disposition, not a discretionary portfolio reduction, and represents a negligible fraction of Oyler's total holdings.
Key Facts
- John Oyler (Director) filed Form 144 to sell 1,949 ADSs on 2026-06-11.
- Estimated proceeds: ~$501,355 (based on 06/10/2026 price).
- Sale is for tax withholding on restricted stock vesting under a registered plan.
- Oyler also sold 4,940 ADSs on 06/08/2026 (~$1.34M), bringing recent total to ~$1.84M.
- The 1,949 ADS sale is ~0.003% of ONC's $29.3B market cap.
Financial Impact
~$501K in proceeds from 1,949 ADSs; tax-motivated, not discretionary.
Risk Factors
- If Oyler files additional Form 144s for open-market sales beyond tax withholding, it could signal reduced conviction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005928 |
| Document: 0001950047-26-005928-index.html | 0001950047-26-005928 |
| Document: 0001950047-26-005928.txt | 0001950047-26-005928 |
Track record
27 reports on ONC
3 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +12.55% at T+60 after the Aug 5, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $416.54 Now $411.29 −1.26% settles Nov 23
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $419.98 Now $411.29 −2.07% settles Nov 18
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $417.33 to $411.29 Now $411.29 −1.45% ▼ −1.45% +0.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $406.96 to $416.54 Now $411.29 +1.06% ▲ +2.35% −0.24% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $387.25 to $415.96 Now $411.29 +6.21% ▲ +7.41% +4.12% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $377.78 to $419.98 Now $411.29 +8.87% ▲ +11.17% +12.08% vs SPY
- Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $361.65 to $350.40 Now $411.29 −13.73% ▲ +3.11% +3.53% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $368.08 to $365.27 Now $411.29 +11.74% ▼ −0.76% +0.42% vs SPY
- Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $346.51 to $350.84 Now $411.29 +18.69% ▲ +1.25% +1.47% vs SPY
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $358.26 to $353.83 Now $411.29 +14.80% ▼ −1.24% −0.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers